Avirulent Salmonella gallinarum variants and pharmaceutical composition using the same
US8481052B2 · kind B2 · utility
1Cited by
6References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 17, 2011 |
| Grant date | Jul 9, 2013 |
| Priority date | — |
| Expiry date | Oct 17, 2031 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to avirulent Salmonella gallinarum variants by inactivating virulence gene clusters of Salmonella gallinarum (SG), a main pathogen of avian salmonellosis, and various uses thereof notably in the production of Salmonella-specific lytic bacteriophages, pharmaceutical compositions and feed additives.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.